0001209191-19-027688.txt : 20190506
0001209191-19-027688.hdr.sgml : 20190506
20190506160843
ACCESSION NUMBER: 0001209191-19-027688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190503
FILED AS OF DATE: 20190506
DATE AS OF CHANGE: 20190506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 19799365
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-03
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2019-05-03
4
M
0
2329
86.52
A
37332
D
Comon Stock
2019-05-03
4
S
0
500
170.33
D
36832
D
Common Stock
2019-05-03
4
S
0
500
171.71
D
36332
D
Common Stock
2019-05-30
4
S
0
707
173.00
D
35625
D
Common Stock
2019-05-03
4
S
0
622
173.72
D
35003
D
Stock Option (Right to Buy)
86.52
2019-05-03
4
M
0
2329
0.00
A
2027-02-02
Common Stock
2329
16310
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $170.33 (range $169.96 to $170.63).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $171.71 (range $171.35 to $172.16).
Open market sales reported on this line occurred at a weighted average price of $173.00 (range $172.54 to $173.39).
Open market sales reported on this line occurred at a weighted average price of $173.72 (range $173.55 to $173.91).
The option vests in 16 quarterly installments from 02/03/2017.
/s/ Omar White, Attorney-in-Fact
2019-05-06